CTOs on the Move

Rockwell Medical Technologies

www.rockwellmed.com

 
Rockwell Medical Technologies, Inc. is a Wixom, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Heather Hunter
SVP, Chief Operating Officer Profile

Similar Companies

Redwood Green Corporation

Redwood Green Corp. delivers high-quality, safe, sustainable, innovative and accessible cannabis-derived products that support individual well-being. Safety and high quality is a critical commitment from Redwood Green, both for our own brands as well as the partners with whom we do business. The drive behind what we do is rooted in improving well-being and quality of life for a wide range of audiences, ensuring we grow and improve upon what is currently available for consumers in the cannabinoids market. The company is publicly traded and listed on the OTC as RDGC.

JBN Scientifica Inc

JBN Scientifica Inc is a Mendham, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Behavioral Health Services

Since 1973, Behavioral Health Services, Inc. has prided itself on providing a continuum of substance abuse treatment services. Each of our programs is based on the philosophy that recovery from addiction is a life-long process.

Cooley Dickinson Hospital

Cooley Dickinson Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Cooley Dickinson Hospital is based in Northampton, MA. You can find more information on Cooley Dickinson Hospital at www.cooley-dickinson.org

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.